E and Id proteins influence invariant NKT cell sublineage differentiation and proliferation

Journal of Immunology

Volumn 192, Issue 5, 2014, Pages 2227-2236

  D'Cruz, Louise M ^b   Stradner, Martin H ^a,b   Yang, Cliff Y ^a   Goldrath, Ananda W ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR OF DIFFERENTIATION 2; INHIBITOR OF DIFFERENTIATION 3; PROTEIN E; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL EXPANSION; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; FETUS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; THYMOCYTE; THYMUS;

ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL PROLIFERATION; INHIBITOR OF DIFFERENTIATION PROTEIN 2; INHIBITOR OF DIFFERENTIATION PROTEINS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, TRANSGENIC; NATURAL KILLER T-CELLS; THYMUS GLAND;

EID: 84896507471     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302904     Document Type: Article

References (44)

1. Brennan, P. J., M. Brigl, and M. B. Brenner. 2013. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat. Rev. Immunol. 13: 101-117.
2. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
3. Berzins, S. P., M. J. Smyth, and A. G. Baxter. 2011. Presumed guilty: natural killer T cell defects and human disease. Nat. Rev. Immunol. 11: 131-142.
4. Montoya, C. J., D. Pollard, J. Martinson, K. Kumari, C. Wasserfall, C. B. Mulder, M. T. Rugeles, M. A. Atkinson, A. L. Landay, and S. B. Wilson. 2007. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology 122: 1-14.
5. Watarai, H., E. Sekine-Kondo, T. Shigeura, Y. Motomura, T. Yasuda, R. Satoh, H. Yoshida, M. Kubo, H. Kawamoto, H. Koseki, and M. Taniguchi. 2012. Development and function of invariant natural killer T cells producing TH2-And TH17-cytokines. PLoS Biol. 10: e1001255.
6. Godfrey, D. I., S. Stankovic, and A. G. Baxter. 2010. Raising the NKT cell family. Nat. Immunol. 11: 197-206.
7. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23: 877-900.
8. Lazarevic, V., A. J. Zullo, M. N. Schweitzer, T. L. Staton, E. M. Gallo, G. R. Crabtree, and L. H. Glimcher. 2009. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat. Immunol. 10: 306-313.
9. Seiler, M. P., R. Mathew, M. K. Liszewski, C. J. Spooner, K. Barr, F. Meng, H. Singh, and A. Bendelac. 2012. Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling. Nat. Immunol. 13: 264-271.
10. Kovalovsky, D., O. U. Uche, S. Eladad, R. M. Hobbs,W. Yi, E. Alonzo, K. Chua, M. Eidson, H. J. Kim, J. S. Im, et al. 2008. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 9: 1055-1064.
11. Savage, A. K., M. G. Constantinides, J. Han, D. Picard, E. Martin, B. Li, O. Lantz, and A. Bendelac. 2008. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29: 391-403.
12. Dose, M., B. P. Sleckman, J. Han, A. L. Bredemeyer, A. Bendelac, and F. Gounari. 2009. Intrathymic proliferation wave essential for Va14+ natural killer T cell development depends on c-Myc. Proc. Natl. Acad. Sci. USA 106: 8641-8646.
13. Mycko, M. P., I. Ferrero, A. Wilson, W. Jiang, T. Bianchi, A. Trumpp, and H. R. MacDonald. 2009. Selective requirement for c-Myc at an early stage of Va14i NKT cell development. J. Immunol. 182: 4641-4648.
14. Allende, M. L., D. Zhou, D. N. Kalkofen, S. Benhamed, G. Tuymetova, C. Borowski, A. Bendelac, and R. L. Proia. 2008. S1P1 receptor expression regulates emergence of NKT cells in peripheral tissues. FASEB J. 22: 307-315.
15. Townsend, M. J., A. S. Weinmann, J. L. Matsuda, R. Salomon, P. J. Farnham, C. A. Biron, L. Gapin, and L. H. Glimcher. 2004. T-bet regulates the terminal maturation and homeostasis of NK and Va14i NKT cells. Immunity 20: 477-494.
16. Ranson, T., C. A. Vosshenrich, E. Corcuff, O. Richard, V. Laloux, A. Lehuen, and J. P. Di Santo. 2003. IL-15 availability conditions homeostasis of peripheral natural killer T cells. Proc. Natl. Acad. Sci. USA 100: 2663-2668.
17. Constantinides, M. G., and A. Bendelac. 2013. Transcriptional regulation of the NKT cell lineage. Curr. Opin. Immunol. 25: 161-167.
18. Lee, Y. J., K. L. Holzapfel, J. Zhu, S. C. Jameson, and K. A. Hogquist. 2013. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 14: 1146-1154.
19. Murre, C. 2005. Helix-loop-helix proteins and lymphocyte development. Nat. Immunol. 6: 1079-1086.
20. Cannarile, M. A., N. A. Lind, R. Rivera, A. D. Sheridan, K. A. Camfield, B. B. Wu, K. P. Cheung, Z. Ding, and A. W. Goldrath. 2006. Transcriptional regulator Id2 mediates CD8+ T cell immunity. Nat. Immunol. 7: 1317-1325.
21. Yang, C. Y., J. A. Best, J. Knell, E. Yang, A. D. Sheridan, A. K. Jesionek, H. S. Li, R. R. Rivera, K. C. Lind, L. M. D'Cruz, et al. 2011. The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets. Nat. Immunol. 12: 1221-1229.
22. Miyazaki, M., R. R. Rivera, K. Miyazaki, Y. C. Lin, Y. Agata, and C. Murre. 2011. The opposing roles of the transcription factor E2A and its antagonist Id3 that orchestrate and enforce the naive fate of T cells. Nat. Immunol. 12: 992-1001.
23. D'Cruz, L. M., K. C. Lind, B. B.Wu, J. K. Fujimoto, and A.W. Goldrath. 2012. Loss of E protein transcription factors E2A and HEB delays memory-precursor formation during the CD8+ T-cell immune response. Eur. J. Immunol. 42: 2031-2041.
24. Verykokakis, M., M. D. Boos, A. Bendelac, E. J. Adams, P. Pereira, and B. L. Kee. 2010. Inhibitor of DNA binding 3 limits development of murine slamassociated adaptor protein-dependent "innate" gd T cells. PLoS ONE 5: e9303.
25. Monticelli, L. A., Y. Yang, J. Knell, L. M. D'Cruz, M. A. Cannarile, I. Engel, M. Kronenberg, and A. W. Goldrath. 2009. Transcriptional regulator Id2 controls survival of hepatic NKT cells. Proc. Natl. Acad. Sci. USA 106: 19461-19466.
26. Alonzo, E. S., R. A. Gottschalk, J. Das, T. Egawa, R. M. Hobbs, P. P. Pandolfi, P. Pereira, K. E. Nichols, G. A. Koretzky, M. S. Jordan, and D. B. Sant'Angelo. 2010. Development of promyelocytic zinc finger and ThPOK-expressing innate gd T cells is controlled by strength of TCR signaling and Id3. J. Immunol. 184: 1268-1279.
27. Ueda-Hayakawa, I., J. Mahlios, and Y. Zhuang. 2009. Id3 restricts the developmental potential of gd lineage during thymopoiesis. J. Immunol. 182: 5306-5316.
28. D'Cruz, L. M., J. Knell, J. K. Fujimoto, and A. W. Goldrath. 2010. An essential role for the transcription factor HEB in thymocyte survival, Tcra rearrangement and the development of natural killer T cells. Nat. Immunol. 11: 240-249.
29. Jones, M. E., and Y. Zhuang. 2007. Acquisition of a functional T cell receptor during T lymphocyte development is enforced by HEB and E2A transcription factors. Immunity 27: 860-870.
30. Pereira, P., and L. Boucontet. 2012. Innate NKTgd and NKTab cells exert similar functions and compete for a thymic niche. Eur. J. Immunol. 42: 1272-1281.
31. Li, J., D. Wu, N. Jiang, and Y. Zhuang. 2013. Combined deletion of Id2 and Id3 genes reveals multiple roles for E proteins in invariant NKT cell development and expansion. J. Immunol. 191: 5052-5064.
32. Masson, F., M. Minnich, M. Olshansky, I. Bilic, A. M. Mount, A. Kallies, T. P. Speed, M. Busslinger, S. L. Nutt, and G. T. Belz. 2013. Id2-mediated inhibition of E2A represses memory CD8+ T cell differentiation. J. Immunol. 190: 4585-4594.
33. Schmitz, R., R. M. Young, M. Ceribelli, S. Jhavar, W. Xiao, M. Zhang, G. Wright, A. L. Shaffer, D. J. Hodson, E. Buras, et al. 2012. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490: 116-120.
34. Seitz, V., P. Butzhammer, B. Hirsch, J. Hecht, I. Gütgemann, A. Ehlers, D. Lenze, E. Oker, A. Sommerfeld, E. von der Wall, et al. 2011. Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma. PLoS ONE 6: e26837.
35. Doulatov, S., F. Notta, K. L. Rice, L. Howell, A. Zelent, J. D. Licht, and J. E. Dick. 2009. PLZF is a regulator of homeostatic and cytokine-induced myeloid development. Genes Dev. 23: 2076-2087.
36. Li, H. S., C. Y. Yang, K. C. Nallaparaju, H. Zhang, Y. J. Liu, A. W. Goldrath, and S. S. Watowich. 2012. The signal transducers STAT5 and STAT3 control expression of Id2 and E2-2 during dendritic cell development. Blood 120: 4363-4373.
37. Matsuda, J. L., L. Gapin, S. Sidobre, W. C. Kieper, J. T. Tan, R. Ceredig, C. D. Surh, and M. Kronenberg. 2002. Homeostasis of Va14i NKT cells. Nat. Immunol. 3: 966-974.
38. Michel, M. L., D. Mendes-da-Cruz, A. C. Keller, M. Lochner, E. Schneider, M. Dy, G. Eberl, and M. C. Leite-de-Moraes. 2008. Critical role of ROR-gt in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc. Natl. Acad. Sci. USA 105: 19845-19850.
39. Hu, T., H. Wang, A. Simmons, S. Bajana, Y. Zhao, S. Kovats, X. H. Sun, and J. Alberola-Ila. 2013. Increased level of E protein activity during invariant NKT development promotes differentiation of invariant NKT2 and invariant NKT17 subsets. J. Immunol. 191: 5065-5073.
40. Terashima, A., H. Watarai, S. Inoue, E. Sekine, R. Nakagawa, K. Hase, C. Iwamura, H. Nakajima, T. Nakayama, and M. Taniguchi. 2008. A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J. Exp. Med. 205: 2727-2733.
41. Engel, I., M. Zhao, D. Kappes, I. Taniuchi, and M. Kronenberg. 2012. The transcription factor Th-POK negatively regulates Th17 differentiation in Va14i NKT cells. Blood 120: 4524-4532.
42. Stock, P., V. Lombardi, V. Kohlrautz, and O. Akbari. 2009. Induction of airway hyperreactivity by IL-25 is dependent on a subset of invariant NKT cells expressing IL-17RB. J. Immunol. 182: 5116-5122.
43. Strober, W., and I. J. Fuss. 2011. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140: 1756-1767.
44. Heller, F., I. J. Fuss, E. E. Nieuwenhuis, R. S. Blumberg, and W. Strober. 2002. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17: 629-638.